Outcome | Comorbidity/risk factor | Significance | Adjusted odds ratio with 95% CI |
---|---|---|---|
Risk of hospital admission | Number of medications | p < .038 | 1.08 (1.01–1.16) |
Heparin | p < .004 | 0.21 (0.07–0.61) | |
Antihypertensive | p < .001 | 0.42 (0.28–0.62) | |
Hyperlipidemia | p < .014 | 1.51 (1.09–2.10) | |
ESRD/CKD | p < .001 | 3.18 (1.72–5.90) | |
Risk of intensive care unit admission | Male gender | p < .045 | 1.45 (1.01–2.08) |
Asian race | p < .018 | 1.79 (1.11–2.89) | |
ESRD/CKD | p < .037 | 1.61 (1.03–2.51) | |
Risk of 30-day mortality | History of malignancy | p < .002 | 3.65 (1.62–8.19) |
ESRD/CKD | p < .027 | 2.575 (1.11–5.96) | |
Risk of readmission within next 30 days | Age | p < .007 | 0.97 (0.95–0.99) |
Polypharmacy ≥ 4 | p < .028 | 2.38 (1.099–5.15) | |
Antihypertensive use | p < .002 | 0.52 (0.35–0.79) | |
Hyperlipidemia | p < .009 | 1.73 (1.15–2.60) |